IP Library › Patent Application 63342264
Patent Application Provisional Small
App. No. 63/342,264 · Confirmation No. 2945

Effective dosage of recombinant serpin-Fc fusion protein for use in a method of treating AAT deficiency in a subject

Applicant: InhibRX, Inc.
Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2024-09-20 N417 Electronic Filing System Acknowledgment Receipt 2 View
2024-09-20 PET.POA.WDRW Request for withdrawal as attorney or agent 3 View
2022-05-24 APP.FILE.REC Filing Receipt 3 View
2022-05-16 SCORE Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) 1 View
2022-05-16 PA.. Power of Attorney 1 View
2022-05-16 PA.. Power of Attorney 1 View
2022-05-16 SPEC Specification 24 View
2022-05-16 CLM Claims 3 View
2022-05-16 ABST Abstract 1 View
2022-05-16 WFEE Fee Worksheet (SB06) 2 View
2022-05-16 N417 Electronic Filing System Acknowledgment Receipt 3 View
2022-05-16 ADS Application Data Sheet 8 View
2022-05-16 DRW.NONBW Drawings-other than black and white line drawings 5 View
2022-05-16 DRW.SUPP Drawings-black and white line and/or other drawings — View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
63/342,264
Filed
2022-05-16